NCT07031440Not yet recruiting
Digital Delivery of Living Well With COPD for Patient Education and Self-management - a Mixed-method Study
Source: ClinicalTrials.gov · Last updated 22 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
COPD (Chronic Obstructive Pulmonary Disease) is a common lung disease. People suffering from COPD typically experience shortness of breath, coughing, and mucus production. The condition is usually treated with medication, but it is equally important that patients are well-informed about COPD and receive guidance on how to live with it. The currently available program, "Living well with COPD (LWWCOPD)," is a patient education and self-management program offered on-site in healthcare institutions (such as the Lung League) over six sessions across six weeks. Studies have shown that participating in this program can improve quality of life and overall health, and COPD patients who have completed it tend to require hospitalization less frequently. However, not all patients who could benefit from the program are able to attend in person-either due to the fixed schedule or because traveling to the training site is too difficult. Therefore, this study aims to determine whether the digital version of the "Living well with COPD" program is equally effective and perhaps more convenient for some patients. The digital version closely mirrors the existing program and consists of various modules that provide information about COPD and practical strategies for managing the disease in daily life. Only once its effectiveness is scientifically proven can the digital version be implemented in Switzerland for COPD patients.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- First submitted
- 12 Jun 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 31 Mar 2028
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Diseases
- COPD
- NCT number
- NCT07031440
What you commit to
- Study type: Interventional
- Planned participants: 140
- From 1 Aug 2025 to the primary completion date, 31 Mar 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Inability to follow the procedures/instructions of the study or to participate in the intervention (e.g. due to language or cognitive barriers, psychological disorders, physical reasons)
Other
- Patients already having completed the conventional LWWCOPD
Who the study is looking for
- Age ≥ 18 years
- Diagnosis of COPD (any stage and severity)
- Able to speak/read/understand German or French
- Access to a cell phone, tablet or personal desktop computer with active internet access
- Willing and able to understand and provide written informed consent
- Current or recent enrolment in a pulmonary rehabilitation program is permitted
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.